IDH2 and acute myeloid leukemia: Notably, although another large cohort of 805 patients found that IDH mutation did not correlate with prognosis, a subset of patients with IDH mutation and CN-AML, NPM1 mutation, and no FLT3-ITD did show significantly reduced OS and RFS (Paschka et al., 2010).